Skip to content

Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia

Effects of Valproic Acid and Magnesium Sulphate on Rocuronium Requirement and Postoperative Analgesia in Patients Undergoing Craniotomy for Cerebrovascular Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01460563
Enrollment
60
Registered
2011-10-27
Start date
2011-10-31
Completion date
2011-12-31
Last updated
2011-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Aneurysm

Keywords

craniotomy, sodium valproate, rocuronium

Brief summary

The investigators hypothesized that valproic acid will increase rocuronium requirement and MgSO4 infusion would reduce requirement of muscle relaxant in craniotomy patients preloaded with sodium valproate.

Detailed description

Magnesium sulfate (MgSO4) is known to reduce requirement of muscle relaxant.

Interventions

DRUGMagnesium Sulfate

MgSO4 infusion: 50mg/kg bolus followed by continuous infusion

DRUG0.9% saline

0.9% saline as same dose as MgSO4 as placebo

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18- 65 years * American society of anesthesiology physical status 1,2 * scheduled for elective craniotomy for aneurysm clipping or for superficial temporal artery-middle cerebral artery anastomosis

Exclusion criteria

body mass index \<18.5 or \>24.9 kg m-2; neuromuscular, renal, cardiovascular or hepatic insufficiency; Glasgow coma scale (GCS) \<15; allergy to the study drugs; medications influencing NDMRs; breast feeding; pregnancy; and preoperative epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
Rocuroniumparticipants will be followed for the duration of the surgery, an expected average of 5.5 hours.Roc 0.15mg/kg is injected when train of four (TOF) becomes 2 which is measured with TOF-watch Sx. The total amount of Roc that injected is recorded. The intervals of each Roc 0.15mg/kg injection will also be recorded.

Secondary

MeasureTime frameDescription
Magnesium concentrationfrom the induction of anesthesia until end of the surgeryserum Magnesium concentration is measured just prior to anesthetic drug administration, 3 hour after the induction of anesthesia, and at the end of the surgery.
side effectsparticipants will be followed for the duration of the surgery, an expected average of 5.5 hours; postoperative 24 hour; postoperative 48 hour.complicaton associated with MgSO4 including muscle weakness, hot flush, and nausea/ vomiting.
hemodynamicsparticipants will be followed for the duration of the surgery, an expected average of 5.5 hours; postoperative 24 hour; postoperative 48 hourmean arterial pressure and heart rate is measured for the duration of the surgery, an expected average of 5.5 hours; postoperative 24 hour; postoperative 48 hour.
total amount of anestheticsparticipants will be followed at the end of the surgery, an expected average of 5.5 hours after induction of anesthesia..total amount of propofol and remifentanil infused is measured.
pain, nausea & vomiting, analgesics use, antiemetics use, nicardipine usepatients will be followed from the end of the operation until postoperativ 48 hPain will be assessed using numeric rating scale at 6 h, 24 h, and 48 h postoperately. Cumulative dose of analgesics and nicardipine, incidence of nicardipine and antiemtics use during 48h postoperatively will be recorded.

Countries

South Korea

Contacts

Primary ContactMihyun Kim, Doctor
snmd56@yahoo.com82-31-787-7499

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026